Long-Term Allergy Treatment: The Only Option That Stops Working After You Stop
The only long-term allergy treatment with randomized-trial evidence for durable post-treatment remission is allergen immunotherapy — SCIT (3-5 year injection course) or SLIT (daily sublingual). Cox, Murphey, and Hankin (Immunol Allergy Clin North Am 2020, PMID 31761122) confirm SCIT is the only disease-modifying allergy therapy. Durham 1999 NEJM: 3-year course produces 4 additional symptom-free years. Daily antihistamines, nasal sprays, and biologics manage symptoms but provide no durability after stopping.
7 peer-reviewed sources
The only long-term allergy treatments with durable post-treatment remission are SCIT (injection course) and SLIT (sublingual). Antihistamines, nasal corticosteroids, and biologics provide effective long-term management but symptoms return on discontinuation — they are not disease-modifying.
The essentials
Long-term allergy treatment divides into two clinically distinct categories. In the first category are treatments that manage allergy over the long term but do not change the underlying disease: daily intranasal corticosteroids (fluticasone propionate, mometasone furoate, triamcinolone, budesonide, beclomethasone), daily second-generation oral antihistamines (loratadine, cetirizine, fexofenadine, desloratadine, levocetirizine), and biologic injections (Xolair/omalizumab anti-IgE; Dupixent/dupilumab anti-IL-4Rα; Tezspire/tezepelumab-ekko anti-TSLP). All of these work well while you take them, but symptoms return when discontinued — they are long-term management without induced tolerance.
In the second category is allergen immunotherapy — SCIT (the 3-to-5-year subcutaneous injection course per Cox 2011 PP3, JACI 2011;127[1 Suppl]:S1-S55) and SLIT (sublingual drops or FDA-approved tablets). These are the only interventions classified as disease-modifying in any peer-reviewed analysis. Cox L, Murphey A, and Hankin C (Immunol Allergy Clin North Am 2020;40[1]:69-85, PMID 31761122) explicitly state that SCIT is the only allergy treatment with long-term remission documented in randomized controlled trials.
The foundational RCT for long-term remission is Durham SR et al (NEJM 1999;341:468-475, PMID 10441602). Grass-pollen-allergic patients who completed a 3-year SCIT course were followed for 4 additional years after discontinuation. Their symptom and medication scores at 4 years off treatment remained as low as patients who had continued receiving injections throughout — demonstrating that the 3-year course produces lasting immune change.
Before starting any long-term immunotherapy course, identifying which allergens are driving symptoms is the essential prerequisite. Curex pairs at-home IgE testing with allergist review to identify which allergens drive symptoms, so the long-term treatment plan targets the right targets — the same diagnostic prerequisite as Cox 2011 SCIT initiation.
The practical decision point for patients is whether they are willing to commit 3-to-5 years upfront for a disease-modifying outcome, or prefer ongoing daily/biweekly treatment that provides excellent symptom control while maintained. Both approaches are clinically valid; only immunotherapy offers the option to eventually stop treatment and maintain benefit.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Efficacy by allergen — what the data shows
Long-term durability is the defining advantage of immunotherapy over pharmacotherapy. The evidence base: Calderón MA et al (Cochrane 2007, 51 RCTs, 2,871 patients) found SCIT produces symptom SMD -0.73 during treatment. Durham SR et al (NEJM 1999) documented that this benefit persists for at least 4 years after stopping a 3-year course. No comparable post-discontinuation data exists for antihistamines, nasal corticosteroids, or biologics — because all three return to pre-treatment symptom levels within days to weeks of stopping.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youCurex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
Treatment options side by side
The long-term treatment spectrum ranges from ongoing daily management (no durability after stopping) to multi-year disease-modifying courses (durable remission after stopping). The right choice depends on patient preference for ongoing treatment versus a defined endpoint.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (Curex SCIT) | |||||
SLIT drops (home sublingual) | |||||
Intranasal corticosteroids (fluticasone, mometasone) | |||||
Biologics (Xolair, Dupixent, Tezspire) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients pursuing the only disease-modifying long-term option, Curex delivers the same SCIT immunotherapy as one weekly shot you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797>, prescribed by a board-certified allergist, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, so the full course finishes without 39 Year-1 clinic visits.
See if at-home shots are right for youFrequently asked questions
Is there a long-term allergy treatment that actually works?
Yes. Allergen immunotherapy — subcutaneous immunotherapy (SCIT, the 3-to-5-year injection course) or sublingual immunotherapy (SLIT) — is the only category of allergy treatment classified as disease-modifying in peer-reviewed literature. Cox L, Murphey A, and Hankin C (Immunol Allergy Clin North Am 2020;40[1]:69-85, PMID 31761122) explicitly stated that SCIT is the only allergy therapy with long-term remission documented in randomized trials. Durham SR et al (NEJM 1999) confirmed that a 3-year grass-pollen SCIT course produced 4 additional years of symptom-free outcomes after stopping — no pharmacotherapy produces comparable post-discontinuation benefit.
How long does long-term allergy treatment (SCIT) last?
A complete SCIT course requires 3-5 years of treatment per Cox 2011 PP3: approximately 6 months of weekly build-up injections (~26-28 visits) followed by 2.5-4.5 years of maintenance injections on a schedule individualized by your allergist. Year 1 involves approximately 39 total clinic visits. After completing the full course, no further injections are typically required. Post-treatment durable remission lasts an average of 4-12 years based on Durham 1999 NEJM and observational follow-up data. For long-term management without a defined endpoint, antihistamines and nasal corticosteroids require indefinite daily use.
Do antihistamines work as a long-term allergy treatment?
Second-generation antihistamines (loratadine, cetirizine, fexofenadine) are effective long-term symptom management when taken daily but are not disease-modifying. They block histamine H1 receptors, reducing the immediate allergic response, but they do not change the underlying IgE sensitization or reduce mast-cell and eosinophil counts in target tissues. When antihistamines are stopped, symptoms return because the allergic immune program has not been changed. Cost-effectiveness analyses show that antihistamines are far cheaper and have vastly better real-world adherence than SCIT, making them appropriate for mild-to-moderate allergic disease or as complementary treatment during the early SCIT build-up phase.
Are biologics like Xolair a long-term cure for allergies?
Biologics like Xolair (omalizumab), Dupixent (dupilumab), and Tezspire (tezepelumab) are effective long-term disease controllers for specific conditions — Xolair for persistent allergic asthma, chronic spontaneous urticaria, and IgE-mediated food allergy; Dupixent for atopic dermatitis and asthma; Tezspire for severe asthma. However, they are not cures and do not induce allergen-specific tolerance. Symptoms return when biologics are discontinued. This is clinically confirmed — unlike SCIT, which has post-discontinuation remission data, no biologic has documented disease-free status years after stopping the drug.
What is the best long-term treatment for seasonal allergies?
For patients with seasonal allergic rhinitis due to confirmed IgE sensitization to a treatable allergen (grass pollen, ragweed, tree pollen, dust mite), allergen immunotherapy — SCIT or SLIT — is the only option with documented post-treatment durability. Cochrane meta-analysis (Calderón 2007, 51 RCTs) found SCIT produces symptom SMD -0.73 versus placebo during treatment; Durham 1999 NEJM showed 4-year post-treatment remission. For patients unable or unwilling to commit to 3-5 years of treatment, high-quality symptom control is achievable with daily intranasal corticosteroids (most effective single pharmacotherapy for nasal symptoms) combined with as-needed antihistamines.
Can children undergo long-term allergy immunotherapy?
Yes. Cox 2011 PP3 supports SCIT in children aged 5 years and older. The pediatric case is particularly compelling because early immunotherapy may prevent asthma development — the PAT study (Jacobsen L et al, Allergy 2007;62:943-948) found that a 3-year pollen SCIT course in allergic-rhinitis children reduced subsequent asthma incidence by approximately half at 10-year follow-up. Möller C et al (JACI 2002) confirmed the asthma-prevention signal. This long-term pediatric benefit — preventing a new disease from developing — represents the most compelling argument for early initiation and is not produced by any pharmacotherapy.
Related Articles
Allergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreTired After Allergy Shots — What the Data Shows | Curex
Fatigue after allergy shots is real and patient-reported — but no peer-reviewed surveillance quantifies its prevalence. Here is what is actually known and what is not.
Read moreAllergy Treatment Shots: SCIT Evidence Guide | Curex
Allergy treatment shots (SCIT): ~39 Year-1 visits per Cox 2011. Cochrane SMD -0.73. Durham 1999: 3-yr course, 4-yr remission. Who qualifies inside.
Read moreAllergy Shot For Humans: SCIT & SLIT Guide
Yes, there is an allergy shot for humans — subcutaneous immunotherapy (SCIT). Cochrane SMD −0.73, 3–5 yr course, at home via Curex $129/mo. Not Cytopoint.
Read moreAllergy Medicine Injection: SCIT vs Biologics vs Steroids | Curex
Allergy medicine injections include SCIT (allergen extract — not a drug), Xolair, Dupixent, and depot steroids. SCIT is the only option with 4-yr post-treatment remission per NEJM 1999.
Read moreAllergy Injection Medication: Complete Category Guide | Curex
Allergy injection medications include SCIT (allergen extract), Xolair, Dupixent, Tezspire, depot steroids, and epinephrine. Only SCIT modifies disease. FDA approval dates and evidence.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
Curex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.